论文部分内容阅读
背景和目的:罗格列酮与阿伐他汀联合疗法已经被证实对于2型糖尿病患者的血糖控制以及脂质水平都有益处。本试验将通过检测罗格列酮与阿伐他汀联合疗法对于2型糖尿病患者的生物标记水平的作用来研究该联合疗法对血管炎的作用。方法:30例患有2型糖尿病和高脂血症的患者被纳入治疗
Background and Objective: Combination therapy with rosiglitazone and atorvastatin has been shown to have both glycemic control and lipid profile benefits in patients with type 2 diabetes. This trial investigates the effect of the combination therapy on vasculitis by examining the effect of rosiglitazone and atorvastatin combination therapy on biomarker levels in patients with type 2 diabetes. Methods: Thirty patients with type 2 diabetes and hyperlipidemia were enrolled in the study